Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer-Reference-Cited by-同舟云学术

Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer

Published:2020-12-07 Issue:2 Volume:15 Page:350-363
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Aguado Cristina¹,Teixido Cristina²³^ORCID,Román Ruth¹,Reyes Roxana⁴,Giménez‐Capitán Ana¹,Marin Elba³⁴,Cabrera Carlos⁵,Viñolas Nuria⁴,Castillo Sergi⁶,Muñoz Silvia⁶,Arcocha Ainara⁴,López‐Vilaró Laura⁷,Sullivan Ivana⁸,Aldeguer Erika¹,Rodríguez Sonia¹,Moya Irene⁵,Viteri Santiago⁵⁹,Cardona Andrés Felipe¹⁰¹¹^ORCID,Palmero Ramon¹²,Sainz Cristina¹³¹⁴,Mesa‐Guzmán Miguel¹⁵,Lozano Maria D.¹⁴¹⁶¹⁷,Aguilar‐Hernández Andrés⁵,Martínez‐Bueno Alejandro⁵,González‐Cao María⁵,Gonzalvo Elena²,Leenders William P. J.¹⁸,Rosell Rafael⁵¹⁹²⁰,Montuenga Luis M.¹³¹⁴¹⁶¹⁷,Prat Aleix³⁴,Molina‐Vila Miguel A.¹^ORCID,Reguart Noemi³⁴^ORCID

Affiliation:

1. Laboratory of Oncology, Pangaea Oncology Quirón Dexeus University Hospital Barcelona Spain

2. Thoracic Oncology Unit Department of Pathology Hospital Clínic Barcelona Spain

3. Translational Genomics and Targeted Therapeutics in Solid Tumors Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain

4. Thoracic Oncology Unit Department of Medical Oncology Hospital Clínic Barcelona Spain

5. Dr Rosell Oncology Institute Dexeus University Hospital Quiron Salud Group Barcelona Spain

6. Division of Medical Oncology Hospital General de Granollers Barcelona Spain

7. Department of Pathology Hospital de la Santa Creu i Sant Pau Barcelona Spain

8. Division of Medical Oncology Hospital de la Santa Creu i Sant Pau Barcelona Spain

9. Dr Rosell Oncology Institute Teknon Medical Center Quiron Salud Group Barcelona Spain

10. Foundation for Clinical and Applied Cancer Research‐FICMAC Bogotá Colombia

11. Clinical and Translational Oncology Group Institute of Oncology Clínica del Country Bogotá Colombia

12. Division of Medical Oncology Catalan Institute of Oncology L'Hospitalet Barcelona Spain

13. Center for Applied Medical Research (CIMA) University of Navarra Spain

14. CIBERONC Madrid Spain

15. Department of Thoracic Surgery University of Navarra Pamplona Spain

16. IDISNA Pamplona Spain

17. Department of Pathology, Anatomy and Physiology School of Medicine University of Navarra Pamplona Spain

18. Department of Biochemistry Radboud Institute for Molecular Life Sciences Nijmegen The Netherlands

19. Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Badalona Spain

20. Universitat Autònoma de Barcelona Bellaterra Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12861

Reference45 articles.

1. MET-dependent solid tumours — molecular diagnosis and targeted therapy

2. Targeting MET in Lung Cancer: Will Expectations Finally Be MET?

3. The multiple paths towards MET receptor addiction in cancer

4. Targeting MET Dysregulation in Cancer

5. MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways;Translational Oncology;2024-02

2. Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments;Frontiers in Oncology;2024-01-11

3. Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment;Scientific Reports;2023-12-01

4. Gene expression signatures in conjunctival fornix aspirates of patients with dry eye disease associated with Meibomian gland dysfunction. A proof-of-concept study;The Ocular Surface;2023-10

5. BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors;Molecular Cancer;2023-07-13